Carrie Lubitz, MD, MPH
Dr. Lubitz received her undergraduate and medical degrees from the University of Michigan. During her general surgery residency at Cornell, she spent two dedicated years studying the genetic basis of thyroid cancer. Following completion of her endocrine surgery fellowship at MGH in 2010, she obtained an MPH at the Harvard School of Public Health, during which time her commitment to health services research, and in particular the application of comparative effectiveness to surgical disease, was solidified. She has had excellent mentored research opportunities, including the Program in Cancer Outcomes Research Training fellowship (2011-2013) and an NCI K07 award (2014-2019). She is now an Associate Professor of Surgery at the Harvard Medical School in the Division of Surgical Oncology, a member of the MGH Endocrine Surgery Unit, and a senior scientist at the Massachusetts General Hospital Institute for Technology Assessment. She holds a number of national leadership positions including the program committee chair and executive council member of the American Association of Endocrine Surgeons and the Recorder of the Association of Academic Surgery.
Her overarching research mission has been to improve the health and well-being of patients with benign and malignant endocrine-related diseases. She is the PI of an R-37 (R01-type merit award) award to examine the potential impact of new diagnostic technologies and personalized management strategies in patients with thyroid cancer using mathematical disease simulation modeling and an American Cancer Society Research Scholar Award to develop a thyroid-cancer specific quality of life index.
Research from the HealthPrism and Safe Surgery/Safe Systems team published in Annals of Surgery Open compares expected versus experienced postoperative health-related quality of life among patients undergoing cancer surgery.
